The Role of Extracellular Vesicles in Neuropsychiatric Disorders
Mirzaahmadi B., Rahbarghazi R., Karimipour M.
Narrative Review on Face & Skin, Systemic / IV, published in Adv Pharm Bull (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Adv Pharm Bull (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41835060
- PMCID
- PMC12980242
- DOI
- 10.34172/apb.025.46020
Abstract (original English)
Purpose There are effective treatments available for neuropsychiatric disorders; however, numerous factors such as misdiagnosis, delayed diagnosis, varying types of onsets and progression of disorder, as well as long timeframes between diagnosis and treatment, all serve to limit the ability of these treatments to reduce symptoms. This article discusses the unique theragnostic aspects of extracellular vesicles (EVs) in relation to these clinical considerations. Methods An extensive review of the literature was conducted to examine recent findings about EVs and their potential role in early diagnosis and targeted treatment of neuropsychiatric disorders, to examine the biological aspects, diagnostic and therapeutic capacity. Results Pathological states radically change the composition of EVs and their cargo delivery, thereby providing a dynamic disease state. EVs can cross biological barriers, have systemic distribution, provide low immunogenicity and toxicity, and all serve to represent the beginnings of identifying early biomarkers and future methods for delivering therapy needed to administer neuroactive drugs/delivery methods. Conclusion In summary, EVs have potential as a theragnostic platform for neuropsychiatric diseases. Because they offer passive, non-invasive, and actionable diagnostic insights, EVs can be applied to therapeutically manage neuropsychiatric disorders, whi
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.
Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.
- 2026
- n = 116
Med Oral Patol Oral Cir Bucal - Level ASystematic ReviewEurope PMC
Stem cell-derived exosomes in tissue regeneration of oral and maxillofacial region: A systematic review
Systematic Review on Chronic Wound, published in Medicine (Baltimore) (2026) — summary generated from the PubMed abstract.
- 2026
Medicine (Baltimore) - Level AMeta-analysisPubMed
Stromal Vascular Fraction-Assisted Fat Grafting: A Systematic Review and Meta-analysis of Clinical Outcomes.
Meta-analysis on Face & Skin, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
Aesthetic Plast Surg - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Osteogenic and Biocompatibility Potential of Polylactic Acid-Based Materials: A Systematic Review of Human Primary Cells Studies
Systematic Review on Face & Skin, published in J Funct Biomater (2026) — summary generated from the PubMed abstract.
- 2026
J Funct Biomater